Brenda L Stevens

This inventor holds 18 USPTO granted patents and 10 published patent applications and 4 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Cytomx Therapeutics, Inc., Silverback Therapeutics, Inc.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brenda L Stevens. Retrieved from https://idiyas.com/inventor/brenda-l-stevens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 10)

% Patents Active = 88.9

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 39(Granted Patents)

Company Filing History:

16 out of 3,742

Bristol-Myers Squibb Compnay

patents

2 out of 94

Cytomx Therapeutics, Inc.

patents

2 out of 6

Silverback Therapeutics, Inc.

patents

4. 1 out of 751

The Rockefeller University

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622954 - ANTI-ICOS AGONIST ANTIBODIES AND USES THEREOF (2026-05-12),

2. 11952427 - Anti-CD40 antibodies and uses thereof (2024-04-09),

3. 11541126 - Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereof (2023-01-03),

4. 11529399 - Anti-ICOS agonist antibodies and uses thereof (2022-12-20),

5. 11306149 - Anti-CD40 antibodies and uses thereof (2022-04-19),

6. 11254740 - Methods of treatment using IL-23p19 monoclonal antibodies (2022-02-22),

7. 11207391 - Anti-ICOS agonist antibodies and uses thereof (2021-12-28),

8. 11179473 - Nectin-4 antibody conjugates and uses thereof (2021-11-23),

9. 10898556 - Anti-ICOS agonist antibodies and uses thereof (2021-01-26),

10. 10844130 - Nucleic acids encoding an anti-CD40 antibody (2020-11-24),

11. 10493140 - Anti-ICOS agonist antibodies and uses thereof (2019-12-03),

12. 10479838 - Antibodies to CD40 with enhanced agonist activity (2019-11-19),

13. 10358490 - Methods of treating inflammation with IL-17A/F and IL-23P19 bispecific antibodies (2019-07-23),

14. 10358489 - IL-23p19 monoclonal antibodies (2019-07-23),

15. 10251945 - Anti-ICOS agonist antibodies and uses thereof (2019-04-09),

Title: Brenda L Stevens - Innovator from Seattle

Introduction: Brenda L Stevens is a pioneering inventor based in Seattle, Washington. With a passion for innovation and a drive to make a difference, she has made significant contributions to the field of technology.

Latest Patents: Brenda L Stevens holds several patents in the areas of artificial intelligence, renewable energy, and sustainable agriculture. Her most recent patent focuses on a groundbreaking method for optimizing solar panel efficiency in varying weather conditions.

Career Highlights: Throughout her career, Brenda L Stevens has worked with top research institutions and leading tech companies to bring her inventions to life. Her dedication to pushing the boundaries of technology has earned her recognition as a trailblazer in the industry.

Collaborations: Brenda L Stevens has collaborated with renowned scientists, engineers, and entrepreneurs to further develop and commercialize her inventions. Her ability to work across disciplines has led to innovative solutions that have the potential to shape the future of various industries.

Conclusion: Brenda L Stevens continues to inspire with her innovative spirit and commitment to creating a more sustainable and technologically advanced world. Her work serves as a testament to the power of ingenuity and perseverance in driving progress and positive change.

Profile summary based on public USPTO records.